Loading…
Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia
The aim of this study was to evaluate levels of serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin) as parameters of disease activity and to monitor the response to treatment in children with acute lympho...
Saved in:
Published in: | European journal of pediatrics 1997-07, Vol.156 (7), p.537-540 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c344t-59bf1589b3489722a1e782fff3f6f6b6839f84165507ed867422db671483bbfa3 |
---|---|
cites | |
container_end_page | 540 |
container_issue | 7 |
container_start_page | 537 |
container_title | European journal of pediatrics |
container_volume | 156 |
creator | HATZISTILIANOU, M ATHANASSIADOU, F AGGURIDAKI, C CATRIU, D |
description | The aim of this study was to evaluate levels of serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin) as parameters of disease activity and to monitor the response to treatment in children with acute lymphoblastic leukaemia (ALL). The above soluble adhesion molecules were determined in the serum of 35 children with ALL and 30 healthy children (control group) of the same age range. The samples were obtained before treatment, 6 months after the beginning of the treatment (remission of the disease), 6 months after the end of the treatment and during relapse of the disease. The mean levels of sICAM-1, sVCAM-1 and sE-selectin at the onset of the disease were 646.6 +/- 80.9 ng/ml, 1786 +/- 151.8 ng/ml and 140.5 +/- 17.3 ng/ml, respectively. These values were significantly higher (P < 0.001) than those of the control group, which were, 245.8 +/- 25.7 ng/ml, 798.6 +/- 78.9 ng/ml and 44.7 +/- 18.2 ng/ml respectively. During remission, the mean levels did not differ significantly from those of the control group. After the end of the treatment the mean levels again did not show any significant differences compared to the control group. During relapse the soluble adhesion molecule mean levels (923.9 +/- 110.1 ng/ml, 2945.7 +/- 349.9 ng/ml and 258.2 +/- 5.1 ng/ml) were significantly higher (P < 0.001) than those of the control group and also than those obtained during remission and after the end of the treatment (P < 0.001). Pearson's correlation coefficient r was computed in order to detect possible linear correlations between: (1) sICAM-1 and sVCAM-1 (r = 0.632); (2) sICAM-1 and sE-selectin (r = 0.788) and (3) sVCAM-1 and sE-selectin (r = 0.752). All three cases correspond to P < 0.001, thus indicating strong linear correlations.
The levels of soluble circulating adhesion molecule levels can be utilized for monitoring disease activity of ALL and its response to treatment, as well as for early detection of relapse. Strong linear correlations between the three soluble adhesion molecules tested suggest that each of them may be sufficient as an indicator. |
doi_str_mv | 10.1007/s004310050657 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79169602</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1323148901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-59bf1589b3489722a1e782fff3f6f6b6839f84165507ed867422db671483bbfa3</originalsourceid><addsrcrecordid>eNpd0EtLxDAUBeAgyjiOLl0KRcRdNa-myVIGXzDgRlcuSpImNmPajkmrzL83YhnQVS6cj0vuAeAUwSsEYXkdIaQkTQVkRbkH5ogSnCNYsn0wh4TCnCEhDsFRjGuYvEB8BmYCJ0XYHLwuXdCjl4Pr3rLY-1F5k8m6MdH1Xdb23qTUZN58Gh8z12W6cb4Opsu-3NBkUo9DSrftpumVl3FwOtnxXZrWyWNwYKWP5mR6F-Dl7vZ5-ZCvnu4flzerXBNKh7wQyqKCC0UoFyXGEpmSY2stscwyxTgRllPEigKWpuaspBjXipWIcqKUlWQBLn_3bkL_MZo4VK2L2ngvO9OPsUo3M8EgTvD8H1z3Y-jS3yqMUSIckoTyX6RDH2MwttoE18qwrRCsfhqv_jSe_Nm0dFStqXd6qjjlF1Muo5beBtlpF3cMpzvS4eQbv1yHnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221960803</pqid></control><display><type>article</type><title>Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia</title><source>Springer Link</source><creator>HATZISTILIANOU, M ; ATHANASSIADOU, F ; AGGURIDAKI, C ; CATRIU, D</creator><creatorcontrib>HATZISTILIANOU, M ; ATHANASSIADOU, F ; AGGURIDAKI, C ; CATRIU, D</creatorcontrib><description>The aim of this study was to evaluate levels of serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin) as parameters of disease activity and to monitor the response to treatment in children with acute lymphoblastic leukaemia (ALL). The above soluble adhesion molecules were determined in the serum of 35 children with ALL and 30 healthy children (control group) of the same age range. The samples were obtained before treatment, 6 months after the beginning of the treatment (remission of the disease), 6 months after the end of the treatment and during relapse of the disease. The mean levels of sICAM-1, sVCAM-1 and sE-selectin at the onset of the disease were 646.6 +/- 80.9 ng/ml, 1786 +/- 151.8 ng/ml and 140.5 +/- 17.3 ng/ml, respectively. These values were significantly higher (P < 0.001) than those of the control group, which were, 245.8 +/- 25.7 ng/ml, 798.6 +/- 78.9 ng/ml and 44.7 +/- 18.2 ng/ml respectively. During remission, the mean levels did not differ significantly from those of the control group. After the end of the treatment the mean levels again did not show any significant differences compared to the control group. During relapse the soluble adhesion molecule mean levels (923.9 +/- 110.1 ng/ml, 2945.7 +/- 349.9 ng/ml and 258.2 +/- 5.1 ng/ml) were significantly higher (P < 0.001) than those of the control group and also than those obtained during remission and after the end of the treatment (P < 0.001). Pearson's correlation coefficient r was computed in order to detect possible linear correlations between: (1) sICAM-1 and sVCAM-1 (r = 0.632); (2) sICAM-1 and sE-selectin (r = 0.788) and (3) sVCAM-1 and sE-selectin (r = 0.752). All three cases correspond to P < 0.001, thus indicating strong linear correlations.
The levels of soluble circulating adhesion molecule levels can be utilized for monitoring disease activity of ALL and its response to treatment, as well as for early detection of relapse. Strong linear correlations between the three soluble adhesion molecules tested suggest that each of them may be sufficient as an indicator.</description><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/s004310050657</identifier><identifier>PMID: 9243236</identifier><identifier>CODEN: EJPEDT</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adolescent ; Antigens ; Biological and medical sciences ; Biomarkers, Tumor ; Case-Control Studies ; Cell adhesion & migration ; Child ; Child, Preschool ; E-Selectin - blood ; Endothelium ; Hematologic and hematopoietic diseases ; Humans ; Infant ; Intercellular Adhesion Molecule-1 - blood ; Leukemia ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Leukocytes ; Medical prognosis ; Medical sciences ; Melanoma ; Metastasis ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy ; Prognosis ; Remission (Medicine) ; Severity of Illness Index ; Vascular Cell Adhesion Molecule-1 - blood</subject><ispartof>European journal of pediatrics, 1997-07, Vol.156 (7), p.537-540</ispartof><rights>1997 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-59bf1589b3489722a1e782fff3f6f6b6839f84165507ed867422db671483bbfa3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2714348$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9243236$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HATZISTILIANOU, M</creatorcontrib><creatorcontrib>ATHANASSIADOU, F</creatorcontrib><creatorcontrib>AGGURIDAKI, C</creatorcontrib><creatorcontrib>CATRIU, D</creatorcontrib><title>Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><description>The aim of this study was to evaluate levels of serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin) as parameters of disease activity and to monitor the response to treatment in children with acute lymphoblastic leukaemia (ALL). The above soluble adhesion molecules were determined in the serum of 35 children with ALL and 30 healthy children (control group) of the same age range. The samples were obtained before treatment, 6 months after the beginning of the treatment (remission of the disease), 6 months after the end of the treatment and during relapse of the disease. The mean levels of sICAM-1, sVCAM-1 and sE-selectin at the onset of the disease were 646.6 +/- 80.9 ng/ml, 1786 +/- 151.8 ng/ml and 140.5 +/- 17.3 ng/ml, respectively. These values were significantly higher (P < 0.001) than those of the control group, which were, 245.8 +/- 25.7 ng/ml, 798.6 +/- 78.9 ng/ml and 44.7 +/- 18.2 ng/ml respectively. During remission, the mean levels did not differ significantly from those of the control group. After the end of the treatment the mean levels again did not show any significant differences compared to the control group. During relapse the soluble adhesion molecule mean levels (923.9 +/- 110.1 ng/ml, 2945.7 +/- 349.9 ng/ml and 258.2 +/- 5.1 ng/ml) were significantly higher (P < 0.001) than those of the control group and also than those obtained during remission and after the end of the treatment (P < 0.001). Pearson's correlation coefficient r was computed in order to detect possible linear correlations between: (1) sICAM-1 and sVCAM-1 (r = 0.632); (2) sICAM-1 and sE-selectin (r = 0.788) and (3) sVCAM-1 and sE-selectin (r = 0.752). All three cases correspond to P < 0.001, thus indicating strong linear correlations.
The levels of soluble circulating adhesion molecule levels can be utilized for monitoring disease activity of ALL and its response to treatment, as well as for early detection of relapse. Strong linear correlations between the three soluble adhesion molecules tested suggest that each of them may be sufficient as an indicator.</description><subject>Adolescent</subject><subject>Antigens</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor</subject><subject>Case-Control Studies</subject><subject>Cell adhesion & migration</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>E-Selectin - blood</subject><subject>Endothelium</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Infant</subject><subject>Intercellular Adhesion Molecule-1 - blood</subject><subject>Leukemia</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Leukocytes</subject><subject>Medical prognosis</subject><subject>Medical sciences</subject><subject>Melanoma</subject><subject>Metastasis</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</subject><subject>Prognosis</subject><subject>Remission (Medicine)</subject><subject>Severity of Illness Index</subject><subject>Vascular Cell Adhesion Molecule-1 - blood</subject><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNpd0EtLxDAUBeAgyjiOLl0KRcRdNa-myVIGXzDgRlcuSpImNmPajkmrzL83YhnQVS6cj0vuAeAUwSsEYXkdIaQkTQVkRbkH5ogSnCNYsn0wh4TCnCEhDsFRjGuYvEB8BmYCJ0XYHLwuXdCjl4Pr3rLY-1F5k8m6MdH1Xdb23qTUZN58Gh8z12W6cb4Opsu-3NBkUo9DSrftpumVl3FwOtnxXZrWyWNwYKWP5mR6F-Dl7vZ5-ZCvnu4flzerXBNKh7wQyqKCC0UoFyXGEpmSY2stscwyxTgRllPEigKWpuaspBjXipWIcqKUlWQBLn_3bkL_MZo4VK2L2ngvO9OPsUo3M8EgTvD8H1z3Y-jS3yqMUSIckoTyX6RDH2MwttoE18qwrRCsfhqv_jSe_Nm0dFStqXd6qjjlF1Muo5beBtlpF3cMpzvS4eQbv1yHnA</recordid><startdate>19970701</startdate><enddate>19970701</enddate><creator>HATZISTILIANOU, M</creator><creator>ATHANASSIADOU, F</creator><creator>AGGURIDAKI, C</creator><creator>CATRIU, D</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>19970701</creationdate><title>Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia</title><author>HATZISTILIANOU, M ; ATHANASSIADOU, F ; AGGURIDAKI, C ; CATRIU, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-59bf1589b3489722a1e782fff3f6f6b6839f84165507ed867422db671483bbfa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adolescent</topic><topic>Antigens</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor</topic><topic>Case-Control Studies</topic><topic>Cell adhesion & migration</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>E-Selectin - blood</topic><topic>Endothelium</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Infant</topic><topic>Intercellular Adhesion Molecule-1 - blood</topic><topic>Leukemia</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Leukocytes</topic><topic>Medical prognosis</topic><topic>Medical sciences</topic><topic>Melanoma</topic><topic>Metastasis</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</topic><topic>Prognosis</topic><topic>Remission (Medicine)</topic><topic>Severity of Illness Index</topic><topic>Vascular Cell Adhesion Molecule-1 - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HATZISTILIANOU, M</creatorcontrib><creatorcontrib>ATHANASSIADOU, F</creatorcontrib><creatorcontrib>AGGURIDAKI, C</creatorcontrib><creatorcontrib>CATRIU, D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Family Health</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HATZISTILIANOU, M</au><au>ATHANASSIADOU, F</au><au>AGGURIDAKI, C</au><au>CATRIU, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia</atitle><jtitle>European journal of pediatrics</jtitle><addtitle>Eur J Pediatr</addtitle><date>1997-07-01</date><risdate>1997</risdate><volume>156</volume><issue>7</issue><spage>537</spage><epage>540</epage><pages>537-540</pages><issn>0340-6199</issn><eissn>1432-1076</eissn><coden>EJPEDT</coden><abstract>The aim of this study was to evaluate levels of serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin) as parameters of disease activity and to monitor the response to treatment in children with acute lymphoblastic leukaemia (ALL). The above soluble adhesion molecules were determined in the serum of 35 children with ALL and 30 healthy children (control group) of the same age range. The samples were obtained before treatment, 6 months after the beginning of the treatment (remission of the disease), 6 months after the end of the treatment and during relapse of the disease. The mean levels of sICAM-1, sVCAM-1 and sE-selectin at the onset of the disease were 646.6 +/- 80.9 ng/ml, 1786 +/- 151.8 ng/ml and 140.5 +/- 17.3 ng/ml, respectively. These values were significantly higher (P < 0.001) than those of the control group, which were, 245.8 +/- 25.7 ng/ml, 798.6 +/- 78.9 ng/ml and 44.7 +/- 18.2 ng/ml respectively. During remission, the mean levels did not differ significantly from those of the control group. After the end of the treatment the mean levels again did not show any significant differences compared to the control group. During relapse the soluble adhesion molecule mean levels (923.9 +/- 110.1 ng/ml, 2945.7 +/- 349.9 ng/ml and 258.2 +/- 5.1 ng/ml) were significantly higher (P < 0.001) than those of the control group and also than those obtained during remission and after the end of the treatment (P < 0.001). Pearson's correlation coefficient r was computed in order to detect possible linear correlations between: (1) sICAM-1 and sVCAM-1 (r = 0.632); (2) sICAM-1 and sE-selectin (r = 0.788) and (3) sVCAM-1 and sE-selectin (r = 0.752). All three cases correspond to P < 0.001, thus indicating strong linear correlations.
The levels of soluble circulating adhesion molecule levels can be utilized for monitoring disease activity of ALL and its response to treatment, as well as for early detection of relapse. Strong linear correlations between the three soluble adhesion molecules tested suggest that each of them may be sufficient as an indicator.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>9243236</pmid><doi>10.1007/s004310050657</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0340-6199 |
ispartof | European journal of pediatrics, 1997-07, Vol.156 (7), p.537-540 |
issn | 0340-6199 1432-1076 |
language | eng |
recordid | cdi_proquest_miscellaneous_79169602 |
source | Springer Link |
subjects | Adolescent Antigens Biological and medical sciences Biomarkers, Tumor Case-Control Studies Cell adhesion & migration Child Child, Preschool E-Selectin - blood Endothelium Hematologic and hematopoietic diseases Humans Infant Intercellular Adhesion Molecule-1 - blood Leukemia Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Leukocytes Medical prognosis Medical sciences Melanoma Metastasis Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Prognosis Remission (Medicine) Severity of Illness Index Vascular Cell Adhesion Molecule-1 - blood |
title | Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukaemia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A32%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20soluble%20adhesion%20molecule%20levels%20in%20children%20with%20acute%20lymphoblastic%20leukaemia&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=HATZISTILIANOU,%20M&rft.date=1997-07-01&rft.volume=156&rft.issue=7&rft.spage=537&rft.epage=540&rft.pages=537-540&rft.issn=0340-6199&rft.eissn=1432-1076&rft.coden=EJPEDT&rft_id=info:doi/10.1007/s004310050657&rft_dat=%3Cproquest_cross%3E1323148901%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c344t-59bf1589b3489722a1e782fff3f6f6b6839f84165507ed867422db671483bbfa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=221960803&rft_id=info:pmid/9243236&rfr_iscdi=true |